Inventaire - your friends and communities are your best library

Epigenetic Silencing of HOPX Promotes Cancer Progression in Colorectal Cancer

Author

Keishi Yamashita

David Sidransky

Akira Ooki

Published in: Neoplasia

Date of publication: July 1, 2012

Language: English

Main subject: colorectal cancer, gene silencing

Bibliographic databases:

Cites articles 36

Date

Title

Authors

May 1986

CpG-rich islands and the function of DNA methylation
May 1, 1993

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study
May 1, 1998

CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth
February 1999

Cancer epigenetics comes of age
December 1, 2001

Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features
January 31, 2001

Breast cancer. Cyr61 is overexpressed, estrogen-inducible, and associated with more advanced disease
December 1, 2002

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma

,
November 1, 2002

Cyr61 promotes breast tumorigenesis and cancer progression
May 1, 2002

CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.
February 18, 2004

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability

, , , ,
February 1, 2004

Correlation of EPHA2 overexpression with high microvessel count in human primary colorectal cancer
September 15, 2005

Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression
August 1, 2005

Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway

, , , ,
March 1, 2005

Global cancer statistics, 2002
January 1, 2005

The evolution of antibodies into versatile tumor-targeting agents
April 1, 2006

PGP9.5 methylation in diffuse-type gastric cancer
April 1, 2006

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer

,
March 1, 2006

Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells
November 16, 2007

The genomic landscapes of human breast and colorectal cancers

, , , , , , , , , , , , , , , ,
October 8, 2007

The N-methyl-D-aspartate receptor type 2A is frequently methylated in human colorectal carcinoma and suppresses cell growth
February 23, 2007

The epigenomics of cancer
January 1, 2007

EphA2 overexpression is associated with angiogenesis in ovarian cancer

,
December 31, 2008

Microsatellite instability at a tetranucleotide repeat in type I endometrial carcinoma
January 1, 2008

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma
July 1, 2009

EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt
February 1, 2009

Clinical significance of tumor markers and an emerging perspective on colorectal cancer
December 1, 2009

Prognostic role of vasculogenic mimicry in colorectal cancer.
March 15, 2010

Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer
February 3, 2010

Neurofilament heavy polypeptide regulates the Akt-beta-catenin pathway in human esophageal squamous cell carcinoma
March 1, 2010

DNA methylation markers in colorectal cancer
January 28, 2010

COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems
January 7, 2010

Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells

Article -

Welcome to inventaire

The library of your friends and communities

Learn more